Physician profile

Vivien Lim

Flushing, NY

NPI 1851302616

$1,605.67

in general payments reported to CMS, 2019-2025

8 companies · $576 in 2025

The $576 reported for 2025 was more than what 81% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$817.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $351.06 2023-2025
Insmed, INC. $268.41 2019
Novo Nordisk INC $249.99 2022
Intuitive Surgical, INC. $180.30 2025
Cvrx, INC. $171.19 2025 Barostim Neo System
Amarin Pharma, INC. $145.00 2019
Janssen Pharmaceuticals, INC $125.00 2019
Baxter Healthcare $114.72 2025 Hillrom - Eli280 Cardiograph

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vivien Lim

$1,605.67

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $576 reported for 2025 was more than what 81% of providers received nationally.

https://glasscript.com/doctor/219522/vivien-lim

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.